In Press: Dr. Nourhan Abdelfattah First Author Paper Published In Nature Communications!

Congratulations to alum Dr. Nourhan Abdelfattah whose first author paper “MiR-584-5p potentiates vincristine and radiation response by inducing spindle defects and DNA damage in medulloblastoma” has been published with Nature Communications! She is also co-author on...
Read More →

In Press: Dr. Sweta Mishra’s First Author Paper In Cell

Congratulations to one of our CSB graduate program alum, Dr. Sweta Mishra whose first author paper ("Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications") has just been published online in Cell!
Read More →

In Press: Dr. Aparna Gorthi Publishes in Nature Journal

Dr. Aparna Gorthi first author paper has just been published in Nature.
Read More →

In Press: Aaron Horning’s First-Author Manuscript Published In Cancer Research!

Congratulations to Aaron Horning, one of our recent PhD graduates, whose first-author manuscript "Single cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle related transcription and attenuated androgen response" was just accepted for...
Read More →

In Press: Amanda Munoz Publishes Her First Author Review In The Current Pharmacology Reports Journal

Congratulations to one of our recent Cancer Biology graduates Dr. Amanda MuA±oz whose first author review on pancreatic cancer has just been published!
Read More →

Bianca Cerqueira & Lauren Cornell’s company NovoThelium was featured in SA Express News!

Bianca Cerqueira and Lauren Cornell company NovoThelium was featured on the My San Antonio from the Express-News! Their company hopes to revolutionize nipple reconstruction using tissue engineering technology so that reconstructed nipples maintain projection, pigmentation, and...
Read More →

Our alum Dr. Stephanie Perez was interviewed in The Society Diaries Magazine!

Our alum Dr. Stephanie Perez was interviewed in The Society Diaries Magazine!
Read More →

Alum David Bearss in The News

Alum David Bearss is now the chief executive officer of Lehi-based biotech firm Tolero Pharmaceuticals, whose team of scientists is conducting clinical trials on a drug that has shown promise in treating acute myeloid leukemia, or AML.
Read More →
Secured By miniOrange